Advertisement

Topics

Minerva Biolabs GmbH Company Profile

20:53 EST 12th December 2018 | BioPortfolio

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva Biolabs GmbH started with innovative products for the effective diagnosis and elimination of mycoplasma contamination in cell cultures and biopharmaceuticals.
2000 The transition to a quality management system (QMS) in accordance with ISO 9001:2000 has been made in November 2000.
2001 Based on our experience with the production of high quality and reliable diagnostics for biopharmaceutical quality control, Minerva Biolabs transferred this know-how to the development of clinical diagnostics for respiratory infections in 2001.
2004 The consequential expansion of our product range led in the beginning of 2004 to the introduction of the worldwide first bacterial diagnostic assay. Another innovative improvement followed the same year by the integration of the Aqua Screen® System into the portfolio of contamination control solutions. The Aqua Screen® System provides a highly efficient method for the filtration and detection of legionella in water. The transition to a quality management system in accordance with ISO 13485:2003 has been made in July 2004.

Location

Landhausring 7
Berlin
D-12683
Germany

Contact

Phone: 49 (0)30 2000 437-0
Fax: 49 (0)30 2000 437-9
Email: info@minerva-biolabs.com


News Articles [221 Associated News Articles listed on BioPortfolio]

Minerva Neurosciences, Inc: Minerva Neurosciences to Present at Evercore ISI HealthCONx Conference on November 28, 2018

WALTHAM, Mass., Nov. 21, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat ...

Minerva Neurosciences, Inc: Minerva Neurosciences Announces Findings Showing Effect of Roluperidone on Brain-Derived Neurotrophic Factor (BDNF)

WALTHAM, Mass., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nerv...

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Second Quarter 2018 Financial Results and Business Updates

Five ongoing late-stage trials on track for data readouts in 2019WALTHAM, Mass., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical com...

Minerva Neurosciences, Inc.: Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

Management to host conference call WALTHAM, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the developmen...

Minerva Neurosciences, Inc: Minerva Neurosciences Reports Third Quarter 2018 Financial Results and Business Updates

Data readouts from five ongoing late-stage trials expected in 2019 WALTHAM, Mass., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical c...

Hologic wins $4.8m in patent infringement lawsuit against Minerva Surgical

The court awarded Hologic $4.8m in damages for Minerva Surgical’s infringement. On June 28, the court ruled that Minerva’s endometrial ablation system infringes the US patents 6,872,183 an...

Cleveland BioLabs, Inc: Cleveland Biolabs Announces Formation and Financing of an Anti-Aging Joint Venture

Goal is to Develop and Commercialize Entolimod and Other Compounds for Anti-aging Applications BUFFALO, NY / ACCESSWIRE / August 14, 2018 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported for...

Minerva Neurosciences, Inc: Minerva Neurosciences to Host Roluperidone Update and Key Opinion Leader Discussion of Negative Symptoms in CNS/Psychiatric Diseases on November 20, 2018

Minerva management to provide update on Phase 3 clinical trial with roluperidone and single-dose escalation study findings Additional topics to include review of recent BDNF data with roluperidone ...

Clinical Trials [52 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

MINERVA: MINimizE Right Ventricular Pacing to Prevent Atrial Fibrillation and Heart Failure

The aim of this study is to test the impact of the managed ventricular pacing (MVP) mode and atrial preventive and antitachycardia pacing therapies on the reduction of a composite clinical...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

A Two-Phase Clinical Study of the Minerva AURORA Ablation System

The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events wil...

Companies [550 Associated Companies listed on BioPortfolio]

Minerva Biolabs GmbH

Minerva Biolabs is committed to providing highest quality in products and services.1999 The company was established in August 1999 as a spin-off from the Robert-Koch Institute (RKI) in Berlin. Minerva...

Minerva Pharmaceuticals

Minerva Pharmaceuticals, Inc. is a biopharmaceutical product development company dedicated to detecting and eliminating cancer before clinical symptoms occur.

Minerva Biotechnologies

Minerva Biotechnologies is a pioneer in the field of stem cells and cancer stem cells. Minerva was first to discover that cancer cells hijack an otherwise normal stem cell growth ...

Torrey Pines Biolabs

Chemokine.com is a product line from Torrey Pines Biolabs, Inc. established in San Diego, California, have been moved to Houston, Texas since January 2001. Torrey Pines Biolabs is an emerging biotechn...

Pacific BioLabs

Pacific BioLabs is an independent laboratory with over 25 years experience providing cGMP/GLP testing services to companies in the Pharmaceutical, Biopharm, Medical Device, Diagnostic and OECD/EPA reg...

More Information about "Minerva Biolabs GmbH" on BioPortfolio

We have published hundreds of Minerva Biolabs GmbH news stories on BioPortfolio along with dozens of Minerva Biolabs GmbH Clinical Trials and PubMed Articles about Minerva Biolabs GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Minerva Biolabs GmbH Companies in our database. You can also find out about relevant Minerva Biolabs GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...


Corporate Database Quicklinks



Searches Linking to this Company Record